Background {#s1}
==========

Streptococcus pneumoniae (S. pneumoniae) infections cause approximately 1.2 million life-threatening illnesses resulting in 7,000 deaths annually including bacterial upper respiratory infections and pneumonia and meningitis, and bloodstream, ear, and sinus infections [@R01],[@R02]. Macrolide antibiotics (i.e. erythromycin and spiramycin) are first line treatments for S. pneumoniae infections [@R03] that function by binding reversibly to the 50S bacterial ribosomal subunit, preventing protein synthesis (translation). Unfortunately, full macrolide resistance in S. pneumoniae, defined clinically by a minimum inhibitory concentration (MIC) greater than 256 mg/mL, is increasingly common [@R03] with approximately 30% of severe S. pneumoniae cases being fully resistant to one or more clinically relevant antibiotics [@R01]. This makes antibioticresistant S. pneumoniae a serious public health threat [@R01]

Several macrolide resistance mechanisms have been reported [@R02]. Known macrolide resistance mechanisms include (1) ribosomal modification, for example via the ermB gene which is responsible for 50S subunit methylation, (2) efflux proteins encoded by major facilitator super-family ormef (E/A), mel, and msrD genes, and (3) ribosomal nucleic acid mutations, which can be either a simple point mutation causing a single amino acid change, such as lysine- 63-glutamaine in the ribosome rplD gene, a deletion of three amino acids (Met-82, Lys-83, and Glu-84) from rplV, or a variety of additional L4 and L22 ribosomal mutations [@R02]-[@R04]. Dual macrolide resistance genotypes our understanding of direct resistance mechanisms further, some macrolide resistant isolates use one of these mechanisms while others use multiple mechanisms with no clear connection to level of resistance [@R02]. Therefore, despite a good understanding of various direct macrolide resistance mechanisms, co-therapies to overcome macrolide resistance have yet to be established.

Mutant library studies have revealed large numbers of genes that both directly, as discussed prior, and indirectly influence drug resistance with many of these genes not clearly involved in known drug-resistant mechanisms [@R05]. Indirect mechanisms associated with resistance can be metabolic, such as decreased Kreb\'s (i.e. TCA) cycle in vancomycin intermediate resistant Staphylococcus aureus [@R06]. One way to uncover genes functioning indirectly with antibiotic resistance mechanisms is to examine gene expression and identify genes with markedly different expression (differentially expressed) between two conditions for further examination (i.e. hypothesis generation). This approach has been used to successfully predict antibiotic resistance in some bacterial pathogens such as Escherichia coli [@R05], but its application to other organisms like S. pneumoniae has been slow. Identifying differentially expressed genes associated with antibiotic resistance is a first step in fully elucidating the interaction between direct and indirect drug-resistance mechanisms.

Incomplete genome annotation substantially limits gene expression analysis [@R07], and is common for bacterial genomes [@R04], [@R08] with up to 50% of some bacterial genomes lacking annotation [@R09]. A hypothetical gene is defined by its sequence alone, having little to no experimental evidence of its function, and lacking homology to genes with known function [@R04], [@R09]. There are two types of hypothetical proteins: (i) uncharacterized protein families that lack domain information and are not usually conserved across phylogenetic lineages, and (ii) domains of unknown function (DUFs), functionally uncharacterized protein sections that have been shown to play essential roles in bacterial processes [@R09], [@R10]. Over 20% of protein domains have DUFs annotations with around 2,700 DUFs found in bacteria and more than 800 DUFs shared between the domains of life [@R10]. Identifying hypothetical genes associated with antibiotic resistance and prioritizing them for experimental characterization, such as structural determination [@R07], could lead to the development of life-saving co-therapies to preclude or overcome antibiotic resistance.

In this paper, we identify and validate genes associated with macrolide resistance by comparing therapeutic response gene expression signatures (list of genes ranked from high to low differential expression between untreated and macrolide treated samples) in S. pneumonia ([Figure 1](#F1){ref-type="fig"}). We noticed these genes were associated with known mechanisms of macrolide resistance, such as efflux, showing our approach�s ability to identify potential cotherapies to overcome macrolide resistance. However, as anticipated, 22 out of 160 (13.75%) macrolide resistance genes identified had hypothetical annotation. To address this, we examined hypothetical genes for DUFs and propose prioritized gene targets related to macrolide resistance for immediate experimental characterization. Through we introduce this approach while exploring erythromycin resistant S. pneumoniae, recommendations provided by applying our approach to other antibiotic resistant bacterial infections can reduce development costs and time to availability for potential new co-therapy targets, substantially renovating the way antibiotic resistant infections are treated clinically.

Methodology {#s2}
===========

Gene expression datasets {#s2a}
------------------------

Macrolide resistant S. pneumoniae samples used in this study came from the Gene Expression Omnibus (GEO) accession GSE54176, which included samples of untreated (n=6) and macrolide treated (1.2mg/L erythromycin n=6, 0.1mg/L spiramycin n=3) macrolide resistant (GA17547, n=2/condition, 6 samples total, and XZ7022, 2 for erythromycin and vehicle, 1 for spiramycin, 5 samples total) and sensitive (XZ8009, n=2 for erythromycin and vehicle, 4 samples total) strains [@R03], [@R11], [@R12]. Gene expression data was used as provided by GEO without alteration.

Identification and validation of macrolide resistance genes Using these expression data, we created erythromycin and spiramycin gene signatures (ranked by T-score) for macrolide resistant GA17547 strain ([Figure 1](#F1){ref-type="fig"}). We used the erythromycin signature as reference and 250 most over- or under-expressed spiramycin genes as query gene sets for Gene Set Enrichment Analysis (GSEA), which calculates a running summation (enrichment score) based on the T-score of matches (hits) between the reference signature and query gene sets [@R13]. From this, we can (i) estimate how similar these signatures are (significance) by calculating a normalized enrichment score (NES) and p-value from 1000 gene permutations, and (ii) identify genes that contribute to achieving maximum enrichment score (i.e. leading-edge genes) associated with macrolide resistance. Leading-edge (93 over- and 67 under-expressed, Table 1 and Table 2, respectively) genes are used for further analysis.

To confirm that identified leading-edge genes are related to resistance, we (i) used leading-edge genes as query gene sets for GSEA with a T-ranked erythromycin response signature from a macrolide sensitive strain (XZ8009) as reference, and (ii) utilized Principal Component Analysis (PCA) and Leave One Out Cross Validation (LOOCV) to examine expression of leading-edge genes in another macrolide resistant strain, XZ7022 ([Figure 1](#F1){ref-type="fig"}). PCA is an unsupervised dimensionality reduction machine-learning technique that visualizes high-dimensional datasets (in our case 67 and 93 dimensions) in 2D space. PCA considers all samples of high dimensional and converts them into principal components, a smaller number of uncorrelated variables. When principal components are plotted in 2D space, variation between samples is observed as separation along principal components. Alternatively, LOOCV will set aside each sample individually (i.e. test set) and calculates a multiple linear regression equation from the remaining samples (i.e. training set). The resulting equation is used to predict the treatment condition of the test set sample. This process is repeated until all samples are left out and accuracy determined from the results.

Functional association and hypothetical gene identification from macrolide resistance genes {#s2b}
-------------------------------------------------------------------------------------------

To identify cellular processes associated with our leading-edge genes, we utilized the Panther search feature [@R14] at the Gene Ontology (GO) knowledgebase [@R15], [@R16], accessed October 17, 2018 ([Figure 1](#F1){ref-type="fig"}). Panther calculates a p-value using the Fisher\'s Exact Test for each user-inputted gene set compared to established gene sets in the GO knowledgebase. For this comparison, we converted each leading-edge gene\'s locus tag provided by GEO to a gene symbol. To do this, we queried the Protein database from the National Center for Biotechnology Information (NCBI) for each locus tag and collected gene symbols from the connected Conserved Domains Database [@R17]. If a locus tag did not have domains in the Conserved Domains Database, we verified its hypothetical status by examining homologs identified via Basic Local Alignment Search Tool Protein (BLASTP) [@R18]. Symbols for all leading-edge genes without exception were included in GO analysis.

Results and Discussion {#s3}
======================

Similarities between erythromycin and spiramycin signatures reveal genes associated with macrolide resistance {#s3a}
-------------------------------------------------------------------------------------------------------------

To identify genes associated with macrolide resistance, we compared erythromycin and spiramycin gene expression signatures with the idea that genes with similar differential expression when erythromycin resistant S. pneumoniaeis treated with different macrolides are associated with macrolide resistance. We observed a statistically significant similarity between erythromycin and spiramycin signatures (p\<0.22, [Figure 2a](#F2){ref-type="fig"}). Of the 250 most over- and under-expressed genes from the spiramycin signature used as query gene sets for comparison to the erythromycin signature, 93 over- and 67 under-expressed genes were identified as contributing most to achieving maximum enrichment score (i.e. leading-edge, [Table 1](#T1){ref-type="table"} and [Table 2](#T2){ref-type="table"}, respectively). We then used each leading-edge gene set as query for GSEA against an erythromycin response signature from a macrolide sensitive S. pneumoniae strain with the hypothesis that these genes would not be differentially expressed in response to macrolide treatment. We observed a relatively random distribution of leading-edge genes across the macrolide response signature (p\> 0.900, [Figure 2b](#F2){ref-type="fig"}), supporting their role in resistance rather than their expression changing as a response to treatment. These genes may contribute to macrolide resistance and become valuable reverse macrolide resistance therapeutic targets.

To confirm that the macrolide resistance genes (leading-edge) we identified are related to resistance, we used PCA to see if expression of these genes in a non-overlapping dataset from a related erythromycin resistant S. pneumoniae strain could separate samples based on treatment (marcrolide or untreated). Both overand under-expressed leading-edge gene sets were able to separate macrolide treated from untreated samples, regardless of which macrolide (erythromycin or spiramycin) was used for treatment ([Figure 3a](#F3){ref-type="fig"}). To quantify this separation ability, we used LOOCV on the same erythromycin resistant S. pneumoniae strain dataset. Multiple linear regression equations derived from these data were successfully able to predict treatment of left out samples with 100% and 80% accuracy for over- and under-expressed leading-edge genes, respectively ([Figure 3b](#F3){ref-type="fig"}). While the sample size used in this study is small and we acknowledge that inclusion of more samples would make findings more robust and prevent over fitting, these results support the conclusion that our leading-edge genes are related to macrolide resistance.

Macrolide resistance genes involved in increased amino acid biosynthesis and decreased ribonucleotide synthesis {#s3b}
---------------------------------------------------------------------------------------------------------------

To identify which cellular processes our macrolide resistant genes (i.e. leading-edge) correspond to most, we compared leading-edge gene lists to gene lists of known biological processes from GO to assess for over-representation via Fisher\'s Exact Test [@R14]-[@R16] \[14-16\]. GO identified 7 of 93 over-expressed leading-edge genes were related to amino acid biosynthesis: dapA, asd, alr, proC, proB, ilvE, and glyA (p=0.024). We noted genes clustered into several processes not identified as over-represented by GO such as 20 transporter genes [@R03] (7 ABC transporters with 2 related to antibiotic resistance, 4 efflux genes with 2 belonging to the major facilitator super family which is responsible for macrolide efflux [@R01] \[19\], and 9 miscellaneous transporter genes) and 8 translation-related genes (including 4 ribosomal subunits). Further, we observed 12 of 67 under-expressed leading-edge genes were associated with organic substance metabolism: ccpA, arc, dltC, sdaA, rnhB, uvrC, lacA, pgi, pyrC, purC, hpt, and upp (p=0.005), with 5 of those genes specializing in ribonucleotide synthesis: pgi, pyrC, purC, hpt, and upp (p=0.014). This shows the capability of our approach to detect known mechanisms of resistance that may or may not be identified by GO [@R19].

Cellular process detection is limited by incomplete genome annotation {#s3c}
---------------------------------------------------------------------

Incomplete genome annotation is a wide-spread challenge to examining cellular processes in bacteria [@R20]. Unfortunately, this study was not immune to this major limitation as we observed 6 of 93 (6.5%) over-expressed and 10 of 67 (14.9%) under-expressed leading-edge genes had hypothetical annotation and confirmed their annotation via BLASTP. Since true hypothetical proteins require experimental investigation, we explored genes with hypothetical annotation further to provide useful recommendations for experimental endeavors. Following such guidance would maximize the potential to identify targets for new therapeutics that preclude and overcome macrolide resistance while minimizing experimental exploration costs.

To this end, we noted 3 over-expressed and 5 under-expressed hypothetical genes encoding DUFs (over-expressed: DUF979, DUF969, DUF389; under-expressed: DUF1447, DUF3042, DUF4649, DUF3884, DUF4231). Since DUFs span across domains of life [@R20], we recommend prioritizing these DUFs for experimental characterization since they may be involved in resistances in other life-threatening infections. Several hypothetical genes related to macrolide resistance did not have domain information yet (overexpressed: SPAR46_0613, SPAR46_1604, SPAR46_1486; underexpressed: SPAR46_0494, SPAR46_1297, SPAR46_0497, SPAR46_1346, SPAR46_1159). We recommend characterizing these over other hypothetical genes found in S. pneumoniae genomes because of their resistance connection.

Conclusion {#s4}
==========

We identified and confirmed macrolide resistance genes in S. pneumoniae that are involved in increased amino acid biosynthesis and decreased ribonucleotide synthesis. Reversing activity for these cellular processes may overcome macrolide resistance. We noted that incomplete genome annotation (i.e. hypothetical genes) is a limitation to our analysis and further explored hypothetical genes related to macrolide resistance to recommend DUFs that are a priority for experimental characterization such as structural determination via nuclear magnetic resonance or X-ray crystallography. Characterization of DUFs identified here has the potential to uncover novel co-therapies that reverse macrolide resistance [@R07], restoring efficacy, not only for S. pneumoniae patients, but across multiple macrolide resistant species, saving thousands of lives annually.

Our gene signature comparison approach to identify DUFs associated with antibiotic resistance is a novel way to prioritize hypothetical genes for experimental characterization. Application of our approach across resistant bacterial infections would be valuable in reducing experimental time and financial costs for identifying new therapeutic targets. However, a major hindrance in these efforts is the availability of datasets run on the same platform. Variations in platforms used in gene expression studies require the use of gene symbols, reducing signature similarities and resulting in detection loss. Regardless, gene expression datasets for antibiotic resistant bacteria using the same platform are publicly available with more being deposited regularly. Results from further analysis could hold far-reaching advancements in treated antibiotic resistant infections globally.

**Edited by P Kangueane**

**Citation:**Goad and Harris, Bioinformation 14(9) 488-498 (2018)

###### Over-expressed leading-edge genes

  Functional Categories1                              Locus tag     Gene symbol   Gene description                                                              Size (amino acids)
  --------------------------------------------------- ------------- ------------- ----------------------------------------------------------------------------- --------------------
  Alpha-amino acid biosynthetic process genes -7.5%   SPAR46_1029   dapA          dihydrodipicolinate synthase                                                  311
                                                      SPAR46_1028   asd           aspartate-semialdehyde dehydrogenase                                          358
                                                      SPAR46_1697   alr           alanine racemase                                                              367
                                                      SPAR46_0936   proC          pyrroline-5-carboxylate reductase                                             265
                                                      SPAR46_0934   proB          glutamate 5-kinase                                                            369
                                                      SPAR46_0842   ilvE          branched-chain amino acid aminotransferase                                    340
                                                      SPAR46_1037   glyA          serine hydroxymethyltransferase family protein                                418
  ABC transporter genes (7.5%)                        SPAR46_2172   pstC          phosphate ABC transporter, permease protein                                   287
                                                      SPAR46_0811   glnQ          ABC transporter family protein                                                240
                                                      SPAR46_1501   glnQ          ABC transporter family protein                                                209
                                                      SPAR46_1502   hisM          ABC transporter protein                                                       213
                                                      SPAR46_2048   yadH          ABC-2 type transporter family protein                                         195
                                                      SPAR46_1653   macA          ABC transporter family protein � macrolide resistance                         171
                                                      SPAR46_1352   mdlB          ABC transporter transmembrane region family protein � multi-drug resistance   582
  Efflux genes (4.3%)                                 SPAR46_0355   rlmL          methyltransferase small domain protein                                        385
                                                      SPAR46_0253   rlmL          acetyltransferase family                                                      231
                                                      SPAR46_0980   mdtG          major facilitator superfamily                                                 399
                                                      SPAR46_1610   MFS1          major facilitator superfamily                                                 383
  Miscellaneous transporter genes -9.6%               SPAR46_1772   secY2         accessory Sec system translocase SecY2                                        405
                                                      SPAR46_0224   secY          preprotein translocase, SecY subunit                                          436
                                                      SPAR46_1562   fieF          cation diffusion facilitator transporter family                               367
                                                      SPAR46_0733   livM          branched-chain amino acid transport system / permease component family        318
                                                      SPAR46_0835   yufQ          branched-chain amino acid transport system / permease component family        272
                                                      SPAR46_0162   metP          binding\--dependent transport system inner membrane component family          230
                                                      SPAR46_1922   dppC          binding\--dependent transport system inner membrane component family          308
                                                      SPAR46_0311   manZ          PTS system mannose/fructose/sorbose IID component family                      272
                                                      SPAR46_1888   pnuC          nicotinamide mononucleotide transporter                                       268
  Exported product genes (3.3%)                       SPAR46_0331   mpa1          polysaccharide export, MPA1 family                                            230
                                                      SPAR46_0349   oppA          bacterial extracellular solute-binding subunit, 5 middle family               660
                                                      SPAR46_1389   hisJ          bacterial extracellular solute-binding subunit, 3 family                      271
  Translation process genes (8.6%)                    SPAR46_0205   rplD          50S ribosomal protein L4                                                      207
                                                      SPAR46_0207   rplB          ribosomal protein L2                                                          277
                                                      SPAR46_0217   rpsN          ribosomal S14p/S29e family protein                                            89
                                                      SPAR46_0218   rpsH          ribosomal S8 family protein                                                   132
                                                      SPAR46_0532   infB          translation initiation factor IF-2                                            624
                                                      SPAR46_1609   truA          tRNA pseudouridine synthase A                                                 249
                                                      SPAR46_1740   fmt           methionyl-tRNA formyltransferase                                              311
                                                      SPAR46_1799   prmA          ribosomal protein L11 methyltransferase                                       316
  Genes with duplicate descriptions (8.6%)            SPAR46_2127   matE          matE family protein                                                           260
                                                      SPAR46_2128   matE          matE family protein                                                           166
                                                      SPAR46_1311   crcB          crcB-like family protein                                                      42
                                                      SPAR46_1312   crcB          crcB-like family protein                                                      124
                                                      SPAR46_1350   ssnA          amidohydrolase family protein                                                 419
                                                      SPAR46_2182   ykuR          amidohydrolase family protein                                                 376
                                                      SPAR46_1183   yigB          HAD hydrolase, IA, variant 1 family protein                                   237
                                                      SPAR46_2126   ysbA          HAD hydrolase, IA, variant 1 family protein                                   206
  Miscellaneous leading-edge genes (35.5%)            SPAR46_0591   rnjA          RNA-metabolizing metallo-beta-lactamase family protein                        553
                                                      SPAR46_1277   topA          DNA topoisomerase I                                                           648
                                                      SPAR46_2293   ctsR          transcriptional regulator CtsR                                                152
                                                      SPAR46_0151   mutR          transcriptional activator, Rgg/GadR/MutR family                               287
                                                      SPAR46_1018   His           histidine triad domain protein                                                189
                                                      SPAR46_2342   yesM          histidine kinase-, DNA gyrase B-, and HSP90-like ATPase family protein        441
                                                      SPAR46_1254   zwf           glucose-6-phosphate dehydrogenase                                             495
                                                      SPAR46_1065   amyA          alpha amylase, catalytic domain protein                                       579
                                                      SPAR46_0033   cynT          carbonic anhydrase family protein                                             165
                                                      SPAR46_1608   thiD          phosphomethylpyrimidine kinase family protein                                 87
                                                      SPAR46_0592   frmB          phospholipase/carboxylesterase family protein                                 259
                                                      SPAR46_0524   cotS          phosphotransferase enzyme family protein                                      243
                                                      SPAR46_1778   rfaJ          glycosyl transferase 8 family protein                                         315
                                                      SPAR46_1173   aceF          2-oxoacid dehydrogenases acyltransferase family protein                       347
                                                      SPAR46_0408   fabH          3-oxoacyl-\[acyl-carrier-\] synthase III family protein                       324
                                                      SPAR46_1564   pcnB          poly A polymerase head domain protein                                         394
                                                      SPAR46_0378   bre           phage integrase family protein                                                101
                                                      SPAR46_0385   cvpA          colicin V production family protein                                           182
                                                      SPAR46_1102   cgtA          obg family GTPase CgtA                                                        436
                                                      SPAR46_0982   rnr           ribonuclease R                                                                784
                                                      SPAR46_1741   priA          primosomal protein N                                                          798
                                                      SPAR46_2124   marR          marR family protein                                                           141
                                                      SPAR46_0264   ssuD          luciferase-like monooxygenase family protein                                  349
                                                      SPAR46_0285   ydiL          CAAX amino terminal protease self- immunity family                            235
                                                      SPAR46_0511   pncU          bacteriocin-type signal sequence domain protein                               82
                                                      SPAR46_1993   cinA          competence or damage-inducible CinA                                           418
                                                      SPAR46_2180   glpG          rhomboid family protein                                                       225
                                                      SPAR46_2181   fau1          5-formyltetrahydrofolate cyclo-ligase                                         179
                                                      SPAR46_2335   yhgE          yhgE or Pip C-terminal domain protein                                         104
                                                      SPAR46_0953   istB          istB-like ATP binding family protein                                          322
                                                      SPAR46_0983   smpB          ssrA-binding protein                                                          155
                                                      SPAR46_1275   cutC          cutC family protein                                                           210
                                                      SPAR46_1300   lemA          lemA family protein                                                           186
  Genes needing improved description (-8.6%)          SPAR46_0361   COG5263       cell wall binding repeat family protein                                       332
                                                      SPAR46_1800   NUDIX         NUDIX domain protein                                                          142
                                                      SPAR46_0330   ywqE          PHP domain protein                                                            243
                                                      SPAR46_0034   prsW          putative membrane protein                                                     219
                                                      SPAR46_2130   gcs2          hypothetical protein                                                          425
                                                      SPAR46_2110   comGF         hypothetical protein                                                          153
                                                      SPAR46_0951   cvfB          hypothetical protein                                                          284
                                                      SPAR46_1607   polY          hypothetical protein                                                          81
  Hypothetical genes (6.5%)                           SPAR46_0844   HP            hypothetical protein - DUF969                                                 104
                                                      SPAR46_0846   HP            hypothetical protein - DUF979                                                 307
                                                      SPAR46_1280   HP            hypothetical protein - DUF389                                                 145
                                                      SPAR46_1604   HP            hypothetical protein - no domain information                                  99
                                                      SPAR46_1486   HP            hypothetical protein - no domain information                                  40
                                                      SPAR46_0613   HP            hypothetical protein - no domain information                                  86

###### Under-expressed leading-edge genes

  Functional Categories1                       Locus tag     Gene symbol   Gene description                                                             Size (amino acids)
  -------------------------------------------- ------------- ------------- ---------------------------------------------------------------------------- --------------------
  Organic substance metabolism genes (17.9%)   SPAR46_2156   pgi           phosphoglucose isomerase family protein                                      426
                                               SPAR46_1178   pyrC          amidohydrolase family protein                                                323
                                               SPAR46_0059   purC          phosphoribosylaminoimidazolesuccinocarboxamide synthase                      235
                                               SPAR46_2363   hpt           hypoxanthine phosphoribosyltransferase                                       180
                                               SPAR46_0728   upp           uracil phosphoribosyltransferase                                             209
                                               SPAR46_2045   ccpA          catabolite control protein A                                                 336
                                               SPAR46_2243   arcC          carbamate kinase                                                             315
                                               SPAR46_2269   dltC          D-alanine\--poly(phosphoribitol) ligase, subunit 2                           79
                                               SPAR46_0121   sdaA          serine dehydratase alpha chain family protein                                132
                                               SPAR46_1166   rnhB          ribonuclease HII family protein                                              260
                                               SPAR46_1894   uvrC          enterocin A Immunity family protein                                          98
                                               SPAR46_1201   lacA          galactose-6-phosphate isomerase, LacA subunit                                141
  ABC transporter genes (6.0%)                 SPAR46_0910   lolD          ABC transporter family protein                                               212
                                               SPAR46_0499   ccmA          ABC transporter family protein                                               243
                                               SPAR46_1716   ccmA          ABC transporter family protein                                               231
                                               SPAR46_1588   AAA           ABC transporter family protein                                               376
  Duplicate genes (6.0%)                       SPAR46_0128   pspA          cell wall binding repeat family protein                                      607
                                               SPAR46_0365   pspA          cell wall binding repeat family protein                                      40
                                               SPAR46_0603   rhoD          rhodanese-like domain protein                                                50
                                               SPAR46_0084   rhoD          rhodanese-like domain protein                                                98
  Miscellaneous leading-edge genes (40.3%)     SPAR46_2241   arcA          arginine deiminase                                                           409
                                               SPAR46_1930   ugpB          bacterial extracellular solute-binding family protein                        419
                                               SPAR46_1929   ugpA          binding-dependent transport system inner membrane component family protein   288
                                               SPAR46_1333   lplB          binding-dependent transport system inner membrane component family protein   310
                                               SPAR46_0095   ompR          transcriptional regulatory family protein                                    232
                                               SPAR46_0607   HIT           HIT domain protein                                                           153
                                               SPAR46_0608   ldcB          D-alanyl-D-alanine carboxypeptidase family protein                           238
                                               SPAR46_0674   ftsQ          POTRA domain, FtsQ-type family protein                                       406
                                               SPAR46_0729   clp           clp protease family protein                                                  196
                                               SPAR46_0999   acm           glycosyl hydrolases 25 family protein                                        250
                                               SPAR46_1135   degV          EDD, DegV family domain protein                                              279
                                               SPAR46_1136   himA          bacterial DNA-binding family protein                                         91
                                               SPAR46_1218   entA          enterocinA Immunity family protein                                           99
                                               SPAR46_1337   insE          transposase family protein                                                   178
                                               SPAR46_1498   manB          phosphoglucomutase/phosphomannomutase                                        60
                                               SPAR46_1575   ridA          endoribonuclease L-PSP family protein                                        126
                                               SPAR46_1649   znuA          periplasmic solute binding family protein                                    71
                                               SPAR46_1673   ROK           ROK family protein                                                           294
                                               SPAR46_1692   nanH          sialidase                                                                    300
                                               SPAR46_1715   gntR          bacterial regulatory subunit, GntR family protein                            121
                                               SPAR46_2023   yhaM          OB-fold nucleic acid binding domain protein                                  308
                                               SPAR46_2024   rmuC          rmuC family protein                                                          418
                                               SPAR46_2025   thiN          thiamine pyrophosphokinase                                                   220
                                               SPAR46_2242   argF          ornithine carbamoyltransferase                                               338
                                               SPAR46_2244   yfcC          C4-dicarboxylate anaerobic carrier family protein                            503
                                               SPAR46_1754   yqeH          ribosome biogenesis GTPase                                                   368
                                               SPAR46_2303   raiA          ribosomal subunit interface protein                                          182
  Genes needing improved description (14.9%)   SPAR46_1934   isl3          hypothetical protein                                                         113
                                               SPAR46_1746   sir2          hypothetical protein                                                         48
                                               SPAR46_1615   fer4          hypothetical protein                                                         38
                                               SPAR46_0749   yutD          hypothetical protein                                                         176
                                               SPAR46_0899   ycgQ          hypothetical protein                                                         271
                                               SPAR46_0292   tra8          hypothetical protein                                                         74
                                               SPAR46_0370   liaF          hypothetical protein                                                         232
                                               SPAR46_1126   ybaB          hypothetical protein                                                         93
                                               SPAR46_0423   yloU          hypothetical protein                                                         129
                                               SPAR46_0432   yloU          hypothetical protein                                                         121
  Hypothetical genes (14.9%)                   SPAR46_0133   HP            hypothetical protein - DUF1447                                               77
                                               SPAR46_0655   HP            hypothetical protein - DUF3042                                               56
                                               SPAR46_1193   HP            hypothetical protein - DUF3884                                               54
                                               SPAR46_1790   HP            hypothetical protein - DUF4649                                               73
                                               SPAR46_1981   HP            hypothetical protein - DUF4231                                               152
                                               SPAR46_0494   HP            hypothetical protein - no domain information                                 118
                                               SPAR46_0497   HP            hypothetical protein - no domain information                                 95
                                               SPAR46_1159   HP            hypothetical protein - no domain information                                 392
                                               SPAR46_1297   HP            hypothetical protein - no domain information                                 105
                                               SPAR46_1346   HP            hypothetical protein - no domain information                                 45

![Schematic representation of study approach. Signatures (ranked list of genes from high to low expression) are created by ranking genes in expression dataset by T-score calculated by comparing untreated and macrolide-treated (either erythromycin or spiramycin) samples collected during mid-log phase of growth. To identify macrolide resistance genes, the erythromycin signature from erythromycin resistant S. pneumoniae strain GA17547 was used as reference and the top and bottom 250 genes from the GA17547 spiramycin signature were used as query gene sets (unranked list of genes with biological relevance) for Gene Set Enrichment Analysis (GSEA) comparison. Gene matches (hits) between the reference signature and query gene set being compared that contribute most to are grouped together as a leading-edge gene set. Leading-edge gene sets were then used (i) as query gene sets for GSEA comparison against a erythromycin gene signature from erythromycin sensitive strain XZ8009 (reference), (ii) to select genes for principal component analysis and leave one out cross validation on erythromycin resistant strain XZ7022, and (iii) for functional analysis by collecting gene symbols, descriptions, and protein domain information from National Center for Biotechnology Information (NCBI) databases then using Gene Ontology to assess lists for overrepresentation to known biological processes gene sets and prioritizing genes without symbols (hypothetical genes) by domain of unknown function detection.](97320630014488F1){#F1}

![Similarities detected between erythromycin (reference) and spiramycin (spira, query gene sets) signatures from an erythromycin resistant S. pneumoniae strain, revealing leading-edge genes. (a) Differential expression of leading-edge genes (query gene sets) was not a response erythromycin treatment as seen by comparison to a erythromycin signature from a macrolide sensitive S. pneumoniae strain (reference). (b) These findings suggest identified leading-edge genes are associated with macrolide resistance rather than response to macrolide treatment.](97320630014488F2){#F2}

![Principal component analysis separates erythromycin resistant samples based on treatment using gene expression values of 93 over- (left) and 67 under-expressed (right) leading-edge genes when plotted along two principal component (PC) that account for the most variation (in parentheses) across samples (a). Leave one out cross validation was used to quantify this separation for both leading-edge gene sets (b). One sample is removed (i.e. test set) and a multivariable logistic regression equation is computed for remaining samples (i.e. training set). The equation is then applied to the test set and based on the value (positive or negative) the program predicts treatment of the test set. Predicted equation values for each test set are plotted (colored dots along x-axes). The average coefficients for each gene across all training set equations is used to create a master equation used to predict treatment of all samples individually and calculate each prediction\'s probability of accuracy (red line).](97320630014488F3){#F3}
